| Literature DB >> 27100832 |
Chia-Shu Lin1, Shih-Yun Wu2,1, Hsin-Yi Huang3, Yu-Lin Lai1,4.
Abstract
Altered sensation (including paresthesia, dysesthesia and hypoesthesia) after mandibular implant surgery may indicate transient or permanent injury of the inferior alveolar nerve and the mental branch, and considerably lower patients' satisfaction about the therapy. Previous studies have shown a great degree of variability on the incidence of altered sensation. We here reported the incidence of altered sensation after mandibular implant surgery based on a meta-analysis of 26 articles published between 1990.1.1 and 2016.1.1. Study quality and risk of bias was assessed and the studies with a lower score were excluded in the meta-analysis. Data synthesis was performed using the logistic-normal random-effect model. The meta-analyses revealed that the short-term (10 days after implant placement) and long-term (1 year after implant placement) incidence was 13% (95% CI, 6%-25%) and 3% (95% CI, 1%-7%), respectively. (2) For the patients who initially reported altered sensation, 80% (95% CI, 52%-94%) of them would return to normal sensation within 6 months after surgery, and 91% (95% CI, 78%-96%) of them would return to normal sensation one year after surgery. We concluded that dentist-patient communication about the risk of altered sensation is critical to treatment planning, since the short-term incidence of altered sensation is substantial (13%). When a patient reports altered sensation, regular assessment for 6 months would help tracing the changes of symptoms. In terms of long-term follow-up (1 year after surgery), the incidence is much lower (3%) and most patients (91%) would return to normal sensation.Entities:
Mesh:
Year: 2016 PMID: 27100832 PMCID: PMC4839635 DOI: 10.1371/journal.pone.0154082
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Search Strategy.
| (A) Computerized search on PubMed/MEDLINE | ||
| Search | Query | Items found |
| #1 | Search (dental OR oral OR "inferior alveolar nerve") AND (implant OR implants) | 42409 |
| #2 | Search ("altered sensation" OR allodynia OR hyperalgesia OR dysaesthesia OR paresthesia OR (sensory disturbance*) OR numbness OR (neurosensory disturbance*) OR "psychological impact" OR "nerve injury" OR neuropathic) | 63147 |
| #3 | Search (#1 AND #2) | 314 |
| #4 | Search (#3 NOT "case reports"[ptyp]) | 266 |
| #5 | Search (#3 NOT "case reports"[ptyp]) Filters: Publication date from 1990/01/01 to 2016/01/01; Humans; English | 182 |
| (B) Computerized search on Cochrane Library | ||
| Publication Year from 1990 to 2016, in Trials, Methods Studies and Technology Assessments | ||
| Search | Query | Items found |
| #1 | Search (dental OR oral OR "inferior alveolar nerve") AND (implant OR implants) | 2730 |
| #2 | Search ("altered sensation" OR allodynia OR hyperalgesia OR dysesthesia OR paresthesia OR "sensory disturbance" OR numbness OR "neurosensory disturbance" OR "psychological impact" OR "nerve injury") | 4716 |
| #3 | Search (#1 AND #2) | 19 |
| #4 | Publication year from 1990/01/01; English | 17 |
Fig 1Flow diagram describing the process of review and study selection.
Demographic and Clinical Characteristics of the Included Studies.
| ID | Source | Design | #Patient (Total/ Female/Male) | Age | Ridge condition | Augmentation procedure |
|---|---|---|---|---|---|---|
| 1 | Boven 2014[ | RS | 40/33/7 | 61 | Height 8.9±2.2 Atrophy VI | Illiac crest onlay bone graft |
| 2 | Kütük 2013[ | RS | 55/NR | NR | RCD ≥5 | NR |
| 3 | Geckiki 2011[ | RS | 23/16/7 | 63 | NR | NR |
| 4 | Bormann 2010[ | NR | 13/8/5 | 56 | RCD >4 | Inter-positional autograft |
| 5a | Felice 2009a[ | RCT | 15/11/4 | 56 | RCD 5–7 | Bio-Oss |
| 5b | Felice 2009a[ | RCT | RCD 5–7 | NR | ||
| 6a | Felice 2009b[ | RCT | 30/15/15 | 55 | RCD 7–8 | Bio-Oss |
| 6b | Felice 2009b[ | RCT | 30/23/7 | 56 | RCD 7–8 | NR |
| 7 | Burnstein 2008[ | NR | 20/NR | NR | RCD <10 | NR |
| 8 | Vazquez 2008[ | PS | 1527/890/637 | 53 | NR | NR |
| 9 | Abarca 2006[ | NR | 65(58)/30/35 | 58 | NR | NR |
| 10 | van der Meij 2005[ | RS | 17/13/4 | 56 | Height 8.5 Atrophy VI | Illiac crest onlay bone graft |
| 11 | Visser 2005[ | RS | 60/39/21 | 54.9 | Height 12–18 Atrophy V-VI Quality 3/2.7 | NR |
| 12 | Frei 2004[ | PS | 50/30/20 | 54 | Height 13.9±2.7 | NR |
| 13 | Tortamano- Neto 2004[ | PS | 10(6)/5/5 | 28–61 | Sufficient bone volume | NR |
| 14 | Walton 2000[ | PS | 75/47/28 | 63 | NR | NR |
| 15 | Bartling 1999[ | PS | 94/43/51 | NR | NR | NR |
| 16 | Allen 1997[ | RS | 60/ NR | NR | NR | NR |
| 17 | Friberg 1997[ | PS | 103/54/49 | 59 | NR | NR |
| 18 | Wismeijer 1997[ | PS | 110(105)/34/76 | 51.5 | NR | NR |
| 19 | Batenburg 1994[ | RS | 57/40/17 | 58 | Atrophy V-VI | NR |
| 20 | Ellies 1993[ | RS | 112(87)/58/29 | 58 | NR | NR |
| 21 | Ellies 1992[ | RS | 212/155/57 | 57 | NR | NR |
| 22 | Johns 1992[ | PS | 133/79/54 | 57 | Quality 1–3 | NR |
| 23 | Åstrand 1991[ | NR | 23/15/8 | 57.7 | NR | NR |
| 24 | Kiyak 1990[ | PS | 39(27)/31/8 | 57.5 | NR | NR |
| 25 | van Steenberghe 1990[ | PS | 159/92/67 | 41–60 | Quality 3–4 | NR |
| 26 | Zarb 1990[ | NR | 46/36/10 | NR | NR | NR |
NR: not reported; PS, prospective cohort study; RCD: ridge-to-canal distance; RCT, randomized control trial; RS, retrospective cohort study.
1The number in the brackets denotes the number of responders.
2Degree of bone atrophy was assessed by Cawood's classification; degree of bone quality was assessed by Lekholm and Zarb's classification; RDC and height is measured in mm.
3The study adopted a within-subject split-mouth design.
4Mean age was calculated based on Table 1 of the study.
5Bone quality was assessed respectively for two study groups.
6Most implants were placed with bone quality between 1 and 3, based on Table 5 of the study.
7The bone quality of 57% of the mandibles was of grade 3 or 4.
Criteria of Assessment of Study Quality and Risk of Bias.
| Original NOQS items | Modified items | Scoring | ||
|---|---|---|---|---|
| Yes | Unclear | |||
| Representativeness of the exposed cohort | (1) | Are the inclusion and exclusion criteria explicitly stated? | 1 | 0 |
| (2) | Are the clinical features of the cohort explicitly stated? | 1 | 0 | |
| Ascertainment of exposure | (3) | Are the surgical procedures explicitly stated? | 1 | 0 |
| Demonstration that outcome of interest was not present at start of study | (4) | Are the methods of assessment of altered sensation explicitly stated? | 1 | 0 |
| Assessment of outcome | (5) | Are the experiences of altered sensation explicitly defined? | 1 | 0 |
| Was follow-up long enough for outcomes to occur | (6) | Is the duration of follow-up explicitly stated? | 1 | 0 |
| Adequacy of follow up of cohorts | (7) | Is the general success/survival rate of implant placement explicitly stated? | 1 | 0 |
Methodological characteristics of the included studies.
| ID | Implant (Length/ Diameter) | Preoperative imaging examination | Assessment of altered sensation | Experience of altered sensation |
|---|---|---|---|---|
| 1 | >10/4.1 | NR | light touch test, pin-prick test | sensory change |
| 2 | NR | Pano | mechanoceptive test | pain (tingling / throbbing) |
| 3 | NR | Pano | NR | pain, paresthesia |
| 4 | 6-12/3.3–4.5 | Pano, DVT | NR | hypoesthesia |
| 5a | 10-13/4 | CT | NR | paresthesia |
| 5b | 5/6 | CT | NR | paresthesia |
| 6a | >10/NR | CT | NR | paresthesia |
| 6b | 7/NR | CT | NR | paresthesia |
| 7 | >5/NR | NR | NR | NR |
| 8 | 6-12/NR | Pano | 2-point discrimination, pin-prick test | hypoesthesia, anesthesia, paresthesia |
| 9 | NR | NR | questionnaire, 2-point discrimination, light touch test, thermal test | neurosensory disturbance |
| 10 | 13-15/3.8–4.5 | Pano | NR | neurosensory disturbance |
| 11 | 11-15/NR | NR | NR | NR |
| 12 | 8-12/4.1–4.8 | Pano, spiral tomograh | NR | paresthesia |
| 13 | 10/4.1 | NR | NR | pain, paresthesia |
| 14 | NR | Pano | questionnaire, light touch test | numb, tingling, painful etc. |
| 15 | NR | Pano, CT | 2-point discrimination, light touch test, thermal test | altered sensation, anesthesia |
| 16 | NR | NR | NR | dysesthesia |
| 17 | 7-20/3.75–4 | NR | NR | disturbed nerve sensation |
| 18 | NR | NR | questionnaire, light touch test, pin-prick test | hypersensitivity, anesthesia |
| 19 | 10-15/3.3–4 | Pano | light touch test | dysesthesia, hypoesthesia, anesthesia |
| 20 | NR | NR | questionnaire | burning, painful etc. |
| 21 | NR | NR | questionnaire | burning, painful etc. |
| 22 | NR | Pano | NR | paresthesia |
| 23 | NR | Pano, tomograph | NR | hypoesthesia, anesthesia |
| 24 | NR | NR | questionnaire | NR |
| 25 | 7-20/3.75–4 | Pano | NR | paresthesia |
| 26 | NR | Pano | NR | NR |
CT: computed tomography; DVT: digital volume tomograph; NR: not reported; Pano: panoramic radiograph.
*All implant length and diameter is measured in mm.
Outcomes of the included studies.
| Short-term | Intermediate-term | Long-term | Other time point of assessment | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ID | Time point of assessment | #Patients | Time point of assessment | #Patients | Time point of assessment | #Patients | Time point of assessment | #Patients | ||||
| 1 | postsurgical | 11 | /40 | NR | NR | NR | at their last recall visit (>5 year) | 5 | /40 | |||
| 2 | postoperative | 10 | /55 | follow-up continued for >6 months | 5 | /55 | follow-up continued for 2 years | 4 | /55 | |||
| 3 | NR | NR | NR | NR | NR | NR | 3-year follow-up | 0 | /23 | |||
| 4 | NR | NR | NR | NR | NR | NR | NR | NR | NR | not explicitly specified | 5 | /13 |
| 5a | after implant placement | 1 | /15 | NR | NR | NR | NR | NR | NR | |||
| 5b | after implant placement | 3 | /15 | NR | NR | NR | NR | NR | NR | |||
| 6a | postoperative | 16 | /30 | NR | NR | NR | NR | NR | NR | |||
| 6b | postoperative | 2 | /30 | NR | NR | NR | NR | NR | NR | |||
| 7 | postoperative | 0 | /20 | NR | NR | NR | NR | NR | NR | |||
| 8 | 1 week after surgery | 2 | /1527 | NR | NR | NR | NR | NR | NR | |||
| 9 | NR | NR | NR | NR | NR | NR | NR | NR | NR | after implant placement (8–24 months) | 19 | /58 |
| 10 | NR | NR | NR | NR | NR | NR | 5.5 years after treatment | 1 | /17 | |||
| 11 | NR | NR | NR | NR | NR | NR | 1 year after prosthesis placement | 0 | /60 | |||
| 12 | postoperative | 2 | /50 | NR | NR | NR | NR | NR | NR | |||
| 13 | NR | NR | NR | 6 months after surgery | 0 | /6 | 1 year after surgery | 0 | /6 | |||
| 14 | NR | NR | NR | 6 months after surgery | 3 | /75 | 1 year after surgery | 1 | /75 | |||
| 15 | within 1 week of surgery | 8 | /94 | 121 days after surgery | 0 | /94 | NR | NR | NR | |||
| 16 | postoperative | 11 | /50 | NR | NR | NR | NR | NR | NR | |||
| 17 | NR | NR | NR | NR | NR | NR | NR | NR | NR | during the entire study period; not-explicitly specified | 1 | /103 |
| 18 | 10 days after surgery | 11 | /103 | NR | NR | NR | 16 months after surgery | 10 | /102 | |||
| 19 | NR | NR | NR | NR | NR | NR | 12–57 months after loading | 0 | /57 | |||
| 20 | 1 week after surgery | 24 | /87 | > 3 months duration | 4 | /87 | > 1 year duration | 1 | /87 | |||
| 21 | 1 week after surgery | 50 | /212 | > 3 months duration | 17 | /212 | > 1 year duration | 4 | /212 | |||
| 22 | after implant placement | 19 | /103 | NR | NR | NR | 1 year after surgery | 1 | /103 | |||
| 23 | NR | NR | NR | NR | NR | NR | 2-year follow-up | 7 | /23 | |||
| 24 | NR | NR | NR | NR | NR | NR | NR | NR | NR | 2 weeks after phase 1 surgery | 14 | /32 |
| 25 | after implant placement | 16 | /91 | NR | NR | NR | 1 year after prosthesis placement | 6 | /91 | |||
| 26 | NR | NR | NR | NR | NR | NR | NR | NR | NR | during the 4–6 years observation after implant placement | 0 | /46 |
NR: not reported.
*The column ‘#patients’ denotes the number of patients who reported altered sensation / the number of patients who received implant placement.
Fig 2Forest plots of the incidence of altered sensation.
(A) The short-term (within 10 days after surgery) incidence. (B) The long-term (1 year after surgery) incidence.
Recovery rate and recovery duration.
| ID | Recovery duration (month) | #Patients recovered to normal sensation | #Patients reported altered sensation | Source of the outcomes | Recovery rate |
|---|---|---|---|---|---|
| 1 | 60 | 6 | 11 | p.629: ‘Eleven patients reported postsurgical sensory disturbances of the mental nerve (objectively and subjectively), five of whom still had a sensory disturbance in the chin region at their last recall visit, but the size of this region had diminished over time.’ | 55% |
| 2 | 1 | 5 | 10 | p.e406: ‘Pain duration of the patients ranged from 1 month to 4 years. Neuropathic pain has continued only for 1 month in 50%, 6 months in 10%, and 2 years in 10% of the patients after the operation.’ | 50% |
| 2 | 6 | 6 | 10 | Same as above | 60% |
| 2 | 24 | 7 | 10 | Same as above | 70% |
| 4 | 1.5 | 5 | 5 | pp.556-557: ‘None of these patients complained of permanent sensory disturbances. The maximum duration of these sensory disturbances was 6 weeks.’ | 100% |
| 5a | 0.1 | 1 | 1 | p.278: ‘No permanent paraesthesia of the alveolar inferior nerve occurred, the longest lasting 3 days.’ | 100% |
| 5b | 0.1 | 3 | 3 | Same as above | 100% |
| 8 | 1.5 | 2 | 2 | p.83: ‘The nerve-altered sensation lasted for 6 weeks and disappeared without treatment.’ | 100% |
| 9 | 3 | 11 | 19 | p.272:‘The duration of this postsurgical neurosensory disturbance after the implant surgery was less than 3 months in 58% (n = 11)’ | 58% |
| 12 | 1 | 2 | 2 | p.493: ‘The altered sensation in the lower lip and the skin area of the chin was present for about three weeks in patient one and four weeks in patient two. After that time, both patients reported normal sensation.’ | 100% |
| 14 | 6 | 15 | 18 | p.466: ‘Although approximately 24% of all subjects reported sensation changes at 2 weeks after stage 1 surgery, only approximately 4% still reported sensory changes at 6 months after initial surgery, dropping to about 1%, 12 months later.’ | 83% |
| 14 | 12 | 17 | 18 | Same as above | 94% |
| 15 | 4 | 8 | 8 | p.1410: ‘All patients had returned to normal nerve function by 121 days after implant placement.’ | 100% |
| 18 | 16 | 5 | 11 | 45% | |
| 20 | 1 | 11 | 20 | 55% | |
| 20 | 6 | 18 | 20 | Same as above | 90% |
| 20 | 12 | 19 | 20 | Same as above | 95% |
| 21 | 1 | 24 | 51 | Table V and p.666: ‘Transient alterations in sensation had resolved by 6 months in more than 80% of patients; however, four patients reported symptoms that resolved after 2 to 3 years (Table V).’ | 47% |
| 21 | 6 | 42 | 51 | Same as above | 82% |
| 21 | 12 | 47 | 51 | Same as above | 92% |
| 22 | 12 | 18 | 19 | p.518: ‘One of the remaining patients still had signs of paresthesia after 1 year of function.’ | 95% |
| 25 | 12 | 10 | 16 | p.277: ‘One year after prosthesis placement, the reported complications were dominated by patients with prosthetic difficulties, such as loosening of gold screws and fractures of the resin material (n = 10). Furthermore, six patients still complained of remaining paresthesia.’ | 63% |
1According to Table 4, 11 patients reported altered sensation on at least on side immediately after implant treatment. Among the 11 patients (No. 47, 49, 59, 69, 73, 77, 80, 85, 86, 87, 98), 5 patients (No. 47, 49, 73, 80, 85) have recovered to normal sensation within 16 months after treatment. The exact duration of altered sensation was not available.
2Only the patients with transient altered sensation (n = 20) were considered here. The patients with persistent changes were excluded because the exact duration of altered sensation was not available from the article.
Fig 3Recovery rate of altered sensation.
(A) The incidence of altered sensation through the duration of follow up. All the studies have assessed the occurrence of altered sensation for at least two different time points, according to the outcomes presented in Table 4. Study IDs of the included studies are shown in the legend. (B) The forest plot for the recovery rate, when recovery duration ≦ 6 months. (C) The forest plot for the recovery rate, when recovery duration = 1 year.